Latest news with #DeepSouth
Yahoo
3 days ago
- Health
- Yahoo
FILAMENT HEALTH ENTERS INTO EXCLUSIVE LICENSE AGREEMENT WITH UNIVERSITY OF ALABAMA AT BIRMINGHAM FOR DATA FROM A CLINICAL TRIAL OF PSILOCYBIN FOR THE TREATMENT OF COCAINE USE DISORDER
The data supports Filament's PEX010 drug development program targeting stimulant use disorders PEX010 is a first-in-class botanical psilocybin drug candidate currently under investigation in 52 clinical trials worldwide for 14 mental health indications VANCOUVER, BC, June 17, 2025 /CNW/ - Filament Health Corp. (OTC: FLHLF) ("Filament" or the "Company"), a clinical–stage natural psychedelic drug development company, today announced that it has entered into an exclusive global license agreement with the University of Alabama at Birmingham (UAB) for intellectual property related to a recently completed Phase 2 placebo-controlled clinical trial of psilocybin as a treatment for cocaine use disorder (CUD). The study investigated the safety and efficacy of a single-dose of psilocybin compared to placebo comparator in 40 adult patients with severe CUD. The trial was led by Principal Investigator Peter Hendricks, Ph.D., University Professor and Heersink Endowed Chair of Psychiatry at the UAB Department of Psychiatry and Behavioral Neurobiology, and a globally recognized expert in psychedelic-assisted therapies for addiction. "The results of the study demonstrated that psilocybin was well-tolerated and that a single dose resulted in a significant and durable reduction in cocaine use among people with CUD who were representative of cocaine users from the Deep South region of the United States. This is notable as most psychedelic trials fail to recruit participants representative of the population of those who could benefit from care.," said Dr. Hendricks. "We expect to have our data published in a peer-reviewed journal later this year and are excited to contribute to the science and possibly help bring to the clinic a promising treatment for cocaine and other stimulant use disorders in the future." Filament has obtained rights to access and use the data, know-how, and associated intellectual property from the clinical study, in furtherance of the Company's own proprietary development programs in stimulant use disorders. The partnership will also enable Dr. Hendricks to serve as an advisor to Filament Health and to advance research into other substance use conditions. "This agreement marks an important step in our mission to advance PEX010 and our other programs for the treatment of patients with stimulant use disorders," said Benjamin Lightburn, Co-Founder and Chief Executive Officer of Filament. "We are a leading developer of psychedelic drug candidates for substance use disorders and other mental health conditions. The positive data from Dr. Hendricks' trial, as well as his knowledge of clinical practices and ongoing counsel, will be significant assets in facilitating the advancement of our research." ABOUT FILAMENT HEALTH (OTC:FLHLF)Filament Health is a clinical-stage natural psychedelic drug development company. We believe that safe, standardized, naturally-derived psychedelic medicines can improve the lives of many, and our mission is to see them in the hands of everyone who needs them as soon as possible. Filament's platform of proprietary intellectual property enables the discovery, development, and delivery of natural psychedelic medicines for clinical development. We are paving the way with the first-ever natural psychedelic drug candidates. Learn more at and on Twitter, Instagram, and LinkedIn. FORWARD LOOKING INFORMATIONCertain statements and information contained in this press release and the documents referred to herein may constitute "forward–looking statements" and "forward–looking information," respectively, under Canadian securities legislation. Generally, forward–looking information can be identified by the use of forward–looking terminology such as, "expect", "anticipate", "continue", "estimate", "may", "will", "should", "believe", "intends", "forecast", "plans", "guidance" and similar expressions are intended to identify forward–looking statements or information. The forward–looking statements are not historical facts, but reflect the current expectations of management of Filament regarding future results or events and are based on information currently available to them. Certain material factors and assumptions were applied in providing these forward–looking statements. Forward–looking statements regarding the Company are based on the Company's estimates and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of Filament to be materially different from those expressed or implied by such forward–looking statements or forward–looking information, including the timing and results of clinical trials, the ability of the parties to receive, in a timely manner and on satisfactory terms, the necessary regulatory, court and shareholders approvals; the ability of the parties to satisfy, in a timely manner, the other conditions to the completion of the proposed business combination; other expectations and assumptions concerning the transactions contemplated in the proposed business combination; the available funds of the parties and the anticipated use of such funds; the availability of financing opportunities; legal and regulatory risks inherent in the psychedelic drug development industry; risks associated with economic conditions, dependence on management and currency risk; risks relating to U.S. regulatory landscape; risks relating to anti-money laundering laws and regulation; other governmental and environmental regulation; public opinion and perception of the psychedelic drug development industry; risks related to the economy generally; risk of litigation; conflicts of interest; risks relating to certain remedies being limited and the difficulty of enforcement of judgments and effect service outside of Canada; and risks related to future acquisitions or dispositions. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward– looking statements and forward–looking information. Filament will not update any forward–looking statements or forward–looking information that are incorporated by reference herein, except as required by applicable securities laws. SOURCE Filament Health Corp. View original content to download multimedia: Sign in to access your portfolio
Yahoo
04-06-2025
- Business
- Yahoo
Zaxby's brings back milkshakes. What flavors are coming? When does half price end?
Need a sweet treat with your Zax Snacks? An old favorite is back at limited stores with more coming. Zaxby's is bringing milkshakes back to its menu after being gone for seven years. Here's what we know, including how to get them in Georgia: The milkshakes are already slowly rolling out to stores, with some already selling it. According to the company's Monday news release, they are expected to be nationwide by June. Zaxby's said, as of this summer, the milkshakes will be on menus permanently. Meaning you don't have to worry about getting them before they are gone. The milkshakes are hand spun and topped with whipped cream, colorful sprinkles, and a Maraschino cherry. They come in vanilla, chocolate, strawberry, and "Birthday Cake" with flavors of baked cake, buttercream, and French vanilla. Zaxby's milkshakes typically start at about $5, but now until June 1, they are being sold at half price: $2.50. You don't need to be part of Zaxby's rewards program to get the sale. All milkshakes are available in only small. Zaxby's online store locator has started marking restaurants with a milkshake icon to identify whether or not they sell the shakes. Currently, they are sold all over Atlanta, Augusta, Athens, and Macon. Savannah currently only has one selling it at 8040 White Bluff Rd. Columbus has a small handful on Auburn Avenue, Bradley Park Drive, Ingersoll Street, Schomburg Road, and Ruffie Way. Miguel Legoas is a Deep South Connect Team Reporter for Gannett/USA Today. Find him on X and Instagram @miguelegoas and email at mlegoas@ This article originally appeared on Savannah Morning News: Zaxby's milkshakes: Price, flavors, and Georgia locations selling them
RNZ News
01-06-2025
- General
- RNZ News
ANZ Premiership live updates: Steel v Pulse
The Pulse are on a roll after a solid victory over the Stars last weekend, while the Steel will be hurting after their one goal loss to the Mystics. However, they're back in front of their Invercargill faithful for what promises to be an exciting encounter in the deep south. Play starts at 4pm NZT. Follow all the action with RNZ's live blog:
Yahoo
31-05-2025
- Climate
- Yahoo
'Severe' geomagnetic storm could spread Northern Lights south to California, Alabama Sunday night
A "severe" geomagnetic storm may be brewing early next week, and many Americans across the nation – perhaps even as far as the Deep South – may be treated to a rare display of the Northern Lights, according to NOAA's Space Weather Prediction Center. A powerful coronal mass ejection (CME), which is a burst of solar material and magnetic fields from the Sun, erupted on Friday night, triggering a Severe Geomagnetic Storm Watch, the SWPC said. What Is A Geomagnetic Storm? The CME will reach Earth on Sunday, when it is expected to produce geomagnetic storms causing disruptions to the planet's magnetosphere. The SWPC issued a level G3 out of 5 (Strong) Geomagnetic Storm Watch for Sunday, and upgraded it to a level G4 (Severe) Geomagnetic Storm Watch for Sunday night into early Monday morning. There is even a chance the storm could reach "Extreme" G5 levels, which were the levels reached during the epic event on May 10, 2024, that spread the Northern Lights to Florida and the Caribbean, according to the SWPC. What Are The 5 Categories That Measure Geomagnetic Storms? While strong geomagnetic storms are harmless to human health, potential impacts include widespread problems with voltage control, along with some issues with the power grid. Additionally, spacecraft may see problems, such as low Earth orbit satellites experiencing increased drag. High-frequency radio signals may be disrupted. On the aesthetic side of things, the geomagnetic storm is expected to produce an aurora that will be visible over much of the northern half of the U.s., with some of the displays potentially dipping down as far south as Alabama and northern California. The forecast looks favorable across much of the U.S., and even in the South except for the Desert Southwest, where remnants of Tropical Storm Alvin are bringing clouds and storms. How To Watch Fox Weather Impacts will lessen come Tuesday, when the geomagnetic storm levels are expected to article source: 'Severe' geomagnetic storm could spread Northern Lights south to California, Alabama Sunday night
Washington Post
22-05-2025
- Politics
- Washington Post
Louisiana Republicans reject bill that would address split jury verdicts, a Jim Crow-era practice
BATON ROUGE, La. — A Louisiana bill that would have carved out a path for incarcerated people convicted by now-banned split juries the opportunity to ask for a new trial was rejected by Republican state senators on Wednesday, likely killing the measure. An estimated 1,000 people behind bars in the Deep South state were convicted by non-unanimous juries, a practice rooted in racism from the era of 'Jim Crow' laws and deemed unconstitutional by the U.S. Supreme Court in 2020. Advocates say it is past time for Louisiana to right a wrong and to give those people a chance at a fair trial.
